Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae.
about
New real-time PCR assay using locked nucleic acid probes to assess prevalence of ParC mutations in fluoroquinolone-susceptible Streptococcus pneumoniae isolates from France.General platform for systematic quantitative evaluation of small-molecule permeability in bacteria.Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaBacterial efflux pump inhibitors from natural sources.Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria.Discovery of novel antibacterials.How to Measure Export via Bacterial Multidrug Resistance Efflux PumpsNovel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.Absence of tmRNA Has a Protective Effect against Fluoroquinolones in Streptococcus pneumoniaeFluorescent Trimethoprim Conjugate Probes To Assess Drug Accumulation in Wild Type and Mutant Escherichia coliIn vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae.Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene.Preincubation of pneumococci with beta-lactams alone or combined with levofloxacin prevents quinolone-induced resistance without increasing intracellular levels of levofloxacin.The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB.Global transcriptome analysis of the responses of a fluoroquinolone-resistant Streptococcus pneumoniae mutant and its parent to ciprofloxacin.Modulation of the Neisseria gonorrhoeae drug efflux conduit MtrE.The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.Fluorimetric Determination of Gatifloxacin in Aqueous, Pure and Pharmaceutical Formulations
P2860
Q34510372-6875BB57-CD4C-4972-9381-9AAA828F7748Q34576251-0EE8942F-518D-4DA9-89EE-06DD0AC57398Q34647294-021D6631-D2C4-4A5A-BC4D-D6ECA1A75C1BQ36673618-7F3FC4C6-7A67-46CE-AA63-46A182B392A8Q36931422-09E66A4E-DB56-490E-AD97-0FF2A2590F6BQ38028520-C77BDFDB-ABCF-4F85-9700-FF351819D1DDQ38887130-7D55D7E4-2F61-4082-AC24-33A43CABF714Q39652276-98AD798F-D3E7-4CCA-B38C-7EDB94B546E4Q41079092-5AE02EDB-F02B-46F1-A763-2865D6E93245Q41484434-4CF6BFF6-7F8A-469B-87E9-7A3843D7203EQ41899401-2DC4DF81-7293-4D4D-981D-74D8111030FAQ42273994-526F2341-A593-4F07-9385-784DC9D1E080Q42408712-5A0643A7-AF3D-483D-A165-9CC34DF0F0CFQ42949270-F62F18BD-181D-4290-B968-939820BF7E2BQ43014021-D1EBCE69-D5DB-403A-9365-918F782618DCQ43181777-925D89D7-C584-484E-9303-9DD8570F6646Q47126036-55AA6C70-23F0-476C-88AB-F10EE9E76474Q49988467-DB924691-FF9E-4282-BFBE-B65AEF8EAD39Q58128406-D7ED6592-E9A5-46CE-AD1B-0E5C20E9B2B3
P2860
Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Accumulation of 10 fluoroquino ...... tant Streptococcus pneumoniae.
@en
Accumulation of 10 fluoroquino ...... tant Streptococcus pneumoniae.
@nl
type
label
Accumulation of 10 fluoroquino ...... tant Streptococcus pneumoniae.
@en
Accumulation of 10 fluoroquino ...... tant Streptococcus pneumoniae.
@nl
prefLabel
Accumulation of 10 fluoroquino ...... tant Streptococcus pneumoniae.
@en
Accumulation of 10 fluoroquino ...... tant Streptococcus pneumoniae.
@nl
P2860
P1476
Accumulation of 10 fluoroquino ...... utant Streptococcus pneumoniae
@en
P2093
M M Johnson
P2860
P304
P356
10.1128/AAC.46.3.813-820.2002
P407
P577
2002-03-01T00:00:00Z